Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders

被引:0
|
作者
Wolfgang Jordan
Henrik Dobrowolny
Sabine Bahn
Hans-Gert Bernstein
Tanja Brigadski
Thomas Frodl
Berend Isermann
Volkmar Lessmann
Jürgen Pilz
Andrea Rodenbeck
Kolja Schiltz
Edzard Schwedhelm
Hayrettin Tumani
Jens Wiltfang
Paul C. Guest
Johann Steiner
机构
[1] Magdeburg Hospital GmbH,Department of Psychiatry and Psychotherapy
[2] University of Goettingen,Department of Psychiatry and Psychotherapy
[3] University of Magdeburg,Department of Psychiatry and Psychotherapy
[4] University of Cambridge,Department of Chemical Engineering and Biotechnology
[5] University of Magdeburg,Institute of Physiology
[6] Center for Behavioral Brain Sciences,Institute of Clinical Chemistry and Pathobiochemistry
[7] University of Magdeburg,Sleep Laboratory, Department of Pneumology
[8] Laboratory of Stress Monitoring,Department of Sleep Medicine and Clinical Chronobiology, Institute of Physiology, St. Hedwig Hospital, Charite
[9] Evangelisches Krankenhaus Goettingen-Weende gGmbH,Institute of Experimental and Clinical Pharmacology and Toxicology
[10] University of Berlin,Department of Neurology
[11] University Medical Center Hamburg-Eppendorf,Department of Biochemistry and Tissue Biology
[12] University of Ulm,undefined
[13] Fachklinik für Neurologie Dietenbronn,undefined
[14] German Center for Neurodegenerative Diseases (DZNE),undefined
[15] University of Campinas (UNICAMP),undefined
来源
European Archives of Psychiatry and Clinical Neuroscience | 2018年 / 268卷
关键词
Oxidative stress; Schizophrenia; Depression; 8-Iso-prostaglandin F2α; Isoprostane; Malondialdehyde; 8-OH-2-deoyxguanosine; Superoxide dismutase; Glutathione ; -transferase;
D O I
暂无
中图分类号
学科分类号
摘要
Oxidative stress and immune dysregulation have been linked to schizophrenia and depression. However, it is unknown whether these factors are related to the pathophysiology or whether they are an epiphenomenon. Inconsistent oxidative stress-related findings in previous studies may have resulted from the use of different biomarkers which show disparate aspects of oxidative stress. Additionally, disease severity, medication, smoking, endocrine stress axis activation and obesity are potential confounders. In order to address some of these shortcomings, we have analyzed a broader set of oxidative stress biomarkers in our exploratory study, including urinary 8-iso-prostaglandin F2α (8-iso-PGF2α), 8-OH-2-deoyxguanosine (8-OH-2-dG), and blood levels of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione S-transferase (GST) in acutely ill drug-naïve first episode patients with schizophrenia (n = 22), major depression (n = 18), and controls (n = 43). Possible confounding factors were considered, and patients were followed-up after 6 weeks of treatment. No differences were observed regarding 8-OH-2-dG, MDA and GST. At baseline, 8-iso-PGF2α levels were higher in patients with schizophrenia (p = 0.004) and major depression (p = 0.037), with a trend toward higher SOD concentrations in schizophrenia (p = 0.053). After treatment, schizophrenia patients showed a further increase in 8-iso-PGF2α (p = 0.016). These results were not related to age, sex, disease severity, medication or adipose tissue mass. However, 8-iso-PGF2α was associated with smoking, endocrine stress axis activation, C-reactive protein levels and low plasma concentrations of brain-derived neurotrophic factor. This study suggests a role of lipid peroxidation particularly in drug-naïve acutely ill schizophrenia patients and highlights the importance of taking into account other confounding factors in biomarker studies.
引用
收藏
页码:129 / 143
页数:14
相关论文
共 50 条
  • [31] Enlarged basal ganglia in drug-naïve patients with first-episode psychosis immediately upon symptom onset
    Yesilkaya, Umit Haluk
    Sen, Meltem
    Yuzbasioglu, Neslihan
    Pence, Kadriye Betul
    Karamustafalioglu, Nesrin
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2024, 37 (01) : 15 - 24
  • [32] Gender differences in prevalence and clinical correlates of anxiety in first-episode and drug-naïve patients with major depressive disorder comorbid with metabolic syndrome
    Gao, Wenqi
    Deng, Zhifang
    Cai, Xiaonan
    Zhang, Dan
    Xiao, Han
    Zhang, Xiangyang
    BMC PSYCHIATRY, 2024, 24 (01)
  • [33] Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
    Chen Lin
    Ke Chen
    Jianjin Yu
    Wei Feng
    Weihong Fu
    Fude Yang
    Xiangyang Zhang
    Dachun Chen
    BMC Psychiatry, 21
  • [34] Comorbid major depression in first-episode drug-naive patients with schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study
    Li, Zezhi
    Xue, Mei
    Zhao, Lei
    Zhou, Yongjie
    Wu, Xi
    Xie, Xiaoxian
    Lang, Xiaoe
    Zhang, Xiangyang
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 294 : 33 - 38
  • [35] Cortical functional mechanisms in emotional cognitive tasks in first-episode, drug-naïve with major depressive disorder: A fNIRS study
    Wan, Xin
    Wu, Yunhong
    Jiang, Wan
    Lu, Xuewen
    Tang, Yimiao
    Yuan, Xin
    Huang, Liping
    Hu, Maorong
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 362 : 698 - 705
  • [36] Dimensional subtyping of first-episode drug-naïve major depressive disorder: A multisite resting-state fMRI study
    Zhang, Biao
    Li, Yating
    Shen, Yuhao
    Zhao, Wenming
    Yu, Yongqiang
    Tang, Jin
    PSYCHIATRY RESEARCH, 2023, 330
  • [37] The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone
    Nikolina Jovanović
    Nada Božina
    Mila Lovrić
    Vesna Medved
    Miro Jakovljević
    Alma Mihaljević Peleš
    European Journal of Clinical Pharmacology, 2010, 66 : 1109 - 1117
  • [38] Individualized multi-modal MRI biomarkers predict 1-year clinical outcome in first-episode drug-naïve schizophrenia patients
    Zhang, Aoxiang
    Yao, Chenyang
    Zhang, Qian
    Zhao, Ziyuan
    Qu, Jiao
    Lui, Su
    Zhao, Youjin
    Gong, Qiyong
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [39] Facial emotion perception abilities are related to grey matter volume in the culmen of cerebellum anterior lobe in drug-naïve patients with first-episode schizophrenia
    Xiaoxin Zhao
    Jingjing Yao
    Yiding Lv
    Xinyue Zhang
    Chongyang Han
    Lijun Chen
    Fangfang Ren
    Qun Zhou
    Zhuma Jin
    Yuan Li
    Yasong Du
    Yuxiu Sui
    Brain Imaging and Behavior, 2022, 16 : 2072 - 2085
  • [40] The role of CYP2D6 and ABCB1 pharmacogenetics in drug-na⟨ve patients with first-episode schizophrenia treated with risperidone
    Jovanovic, Nikolina
    Bozina, Nada
    Lovric, Mila
    Medved, Vesna
    Jakovljevic, Miro
    Peles, Alma Mihaljevic
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (11) : 1109 - 1117